Tycho Baumann
Overview
Explore the profile of Tycho Baumann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
3188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodenas Quinonero I, Marco-Ayala J, Chen-Liang T, de la Cruz-Vicente F, Baumann T, Navarro J, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766089
Background: Assessment of bone marrow infiltration (BMI) is part of the initial staging of mantle cell lymphoma (MCL), although BMI evaluated by biopsy (BMB) is not considered significant in the...
2.
Rivas-Delgado A, Lopez C, Clot G, Nadeu F, Grau M, Frigola G, et al.
Hemasphere
. 2024 Oct;
8(10):e70024.
PMID: 39380845
Testicular large B-cell lymphoma (TLBCL) is an infrequent and aggressive lymphoma arising in an immune-privileged site and has recently been recognized as a distinct entity from diffuse large B-cell lymphoma...
3.
Jimenez-Ubieto A, Martin-Munoz A, Poza M, Dorado S, Garcia-Ortiz A, Revilla E, et al.
Front Immunol
. 2024 Jan;
14:1349296.
PMID: 38268917
[This corrects the article DOI: 10.3389/fimmu.2023.1188818.].
4.
Jimenez-Ubieto A, Martin-Munoz A, Poza M, Dorado S, Garcia-Ortiz A, Revilla E, et al.
Front Immunol
. 2023 Sep;
14:1243241.
PMID: 37662957
[This corrects the article DOI: 10.3389/fimmu.2023.1188818.].
5.
Syrykh C, Pons-Brun B, Russinol N, Playa-Albinyana H, Baumann T, Duran-Ferrer M, et al.
Blood Adv
. 2023 Jul;
7(23):7384-7391.
PMID: 37505099
No abstract available.
6.
Jimenez-Ubieto A, Martin-Munoz A, Poza M, Dorado S, Garcia-Ortiz A, Revilla E, et al.
Front Immunol
. 2023 Jun;
14:1188818.
PMID: 37342332
Background: CART therapy has produced a paradigm shift in the treatment of relapsing FL patients. Strategies to optimize disease surveillance after these therapies are increasingly necessary. This study explores the...
7.
Jimenez-Ubieto A, Poza M, Martin-Munoz A, Ruiz-Heredia Y, Dorado S, Figaredo G, et al.
Leukemia
. 2023 Jan;
37(3):659-669.
PMID: 36596983
In the present study, we screened 84 Follicular Lymphoma patients for somatic mutations suitable as liquid biopsy MRD biomarkers using a targeted next-generation sequencing (NGS) panel. We found trackable mutations...
8.
de la Serna J, Baumann T
Lancet Haematol
. 2022 Aug;
9(10):e711-e712.
PMID: 35988548
No abstract available.
9.
Ramos-Campoy S, Puiggros A, Kamaso J, Bea S, Bougeon S, Larrayoz M, et al.
Cancers (Basel)
. 2022 Aug;
14(15).
PMID: 35954380
Chromothripsis (cth) has been associated with a dismal outcome and poor prognosis factors in patients with chronic lymphocytic leukemia (CLL). Despite being correlated with high genome instability, previous studies have...
10.
Nadeu F, Royo R, Massoni-Badosa R, Playa-Albinyana H, Garcia-Torre B, Duran-Ferrer M, et al.
Nat Med
. 2022 Aug;
28(8):1662-1671.
PMID: 35953718
Richter transformation (RT) is a paradigmatic evolution of chronic lymphocytic leukemia (CLL) into a very aggressive large B cell lymphoma conferring a dismal prognosis. The mechanisms driving RT remain largely...